|

Olanzapine 2.5 MG Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Also known as: OLN2.5

Pipeline

Phase 3: 3

Top Sponsors

  • Qinghai Red Cross Hospital1
  • Mahidol University1
  • Blokhin's Russian Cancer Research Center1

Indications

  • Cancer3
  • Oncology Patients Receiving Chemotherapy1
  • Olanzapine1
  • Anorexia1
  • Cachexia-Anorexia Syndrome1

Other3 trials

Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Phase 3
Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy
Phase 3
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.